Dermatology Research

The Alfred dermatology research team are leaders in their fields, with decades of Australian and international experience.

Focus areas

Our researchers are focussed on new treatments for common skin conditions such as eczema and psoriasis as well as advancements in the treatment of more rare conditions such as vitiligo, hidradenitis suppurativa, bullous pemphigoid and urticaria.

Achievements

Professor Johannes Kern (Alfred Dermatology/Monash Central Clinical School) together with Dr Asolina Braun (Monash Biomedicine Discovery Institute) received a LEO Foundation grant for their project to identify antigen triggers of psoriasis.

Alfred dermatology clinical trials participate in the Medical Research Future Funds (MRFF) funded SiroSkin trial on prevention of skin squamous cell carcinoma in solid organ transplant recipients.

Professor Johannes Kern is the global coordinating investigator of the CSL324_1002 phase IB, first in-patient trial, for patients with palmoplantar pustulosis and hidradenitis suppurativa.

Our Team

Prof Johannes S Kern

Johannes is a conjoint Professor and Director of Dermatology, Monash University School of Translational Medicine and Alfred Health and Co-Head of the Monash University SkIIN Discovery Program.

Find out more
A/Prof Sue Yen Michelle Goh

A/Prof Michelle Goh is a Fellow of the Australasian College of Dermatologists (FACD).

Find out more
Dr Charlotte Krones

Charlotte, our Clinic and Trials Fellow, is a strong patient advocate and has a strong emphasis on patient-centred care.

Find out more
Dr Priska McDonald
Dr Thuvarahan Jegathees
Find out more

Are you interested in our dermatology clinical trials?

The unit is focused on new treatments for common conditions such as eczema and psoriasis as well as advancements in the treatment of more rare conditions.

Read more

Publications

Informing a position statement on the use of artificial intelligence in dermatology in Australia

Caffery LJ, Janda M, Miller R, Abbott LM, Arnold C, Caccetta T, Guitera P, Shumack S, Fernández-Peñas P, Mar V, Soyer HP

(2023), Australasian journal of dermatology, 64(1), e11-20

DOI: 10.1111/ajd.13946

Cancer Treatment Patterns and Factors Affecting Receipt of Treatment in Older Adults: Results from the ASPREE Cancer Treatment Substudy (ACTS)

Muhandiramge J, Warner ET, Zalcberg JR, Haydon A, Polekhina G, van Londen GJ, Gibbs P, Bernstein WB, Tie J, Millar JL, Mar VJ, McNeil JJ, Woods RL, Orchard SG; ASPREE Investigator Group

(2023), Cancers, 15(4), 1017

DOI: 10.3390/cancers15041017

CSL324, a granulocyte colony-stimulating factor receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativa

Gamell, Cristina; Bankovacki, Alexandra; Scalzo-Inguanti, Karen; Sedgmen, Bradley J; Alhamdoosh, Monther; Gail, Emma; Turkovic, Lydia; Millar, Christine; Johnson, Laura; Wahlsten, Michelle; Richter, Jim; Schuster, Jared; Dyson, Allison; Nicolopoulos, Jenn

(2023), British Journal of Dermatology, 188(5), 636-648

DOI: 10.1093/bjd/ljad013

View all publications for Dermatology Research
News & articles
from Alfred Health
Read latest news